Angel Funding Part 2 - Due Diligence: People, Processes and PromisesThursday April 21, 11:45 - 2:00pm in the Cafe @ LearnLaunch 281 Summer Street, 2nd Floor, Boston
You did it: you’ve got some customers, you’ve pitched, you’ve networked, you’ve grown… but now what?
There’s a whole lot to understand between pitching to an Angel Group and the final handshake. We’ll walk you through the post pitching inquiry process, due diligence rounds and how they differ from group to group: from high level overviews, to in-depth analyses of every number, customer and flaw, our Angel experts will let you in on what they expect, hope for and get turned off by so you can be prepared. We recommend for you to have attended our ‘Apply for Angel Funding with an Investor’s Perspective’ workshop.
To prepare for this workshop, you can read Christopher Mirabile’s Inc article: ‘Rites of Passage: What Investors Mean By Due Diligence’
Jean Hammond is an active angel investor focusing on early stage high tech start-ups. She was honored with the highest award for angels in the US, the Hans Severiens Award in 2014. She is a co-founder and a partner at Learn Launch and was a founder of the Boston branch of Golden Seeds (focused on investing in women-managed businesses) and a member of Launchpad Venture Group and Hub Angels. Jean is serial entrepreneur with over 20 years experience in the high-tech industry. Her entrepreneurial activities include co-founding and managing Quarry Technologies and AXON Networks and, following 3Com’s acquisition of AXON, focusing 3Com’s WAN strategy.
Norman Meisner is an angel investor associated with Beta Fund and Launchpad Venture Group, making angel investments in high tech start ups in the greater Boston area. He is a Principal in the Beta Fund, a Micro VC fund investing in early stage high tech and biotech companies. An active member of the Launchpad Venture Group, the Boston area’s largest and most active angel investment group and a Board observer and advisor for a few companies, including Content Raven (a company providing secure document and video delivery) Crowdly (advocate marketing software to help brands increase brand advocacy and word-of-mouth) and Kalion (an industrial biotech company)
Ben Littauer is a business and technology management consultant with expertise in Internet and communications technologies, as well as healthcare IT and is an active angel investor, member of Boston Harbor Angels. Ben was Technology Strategist for Beth Israel Deaconess Medical Center in Boston, where he defined the architecture for PatientSite, a system that allows patients to communicate securely with their healthcare team and view their own medical records. He also was a consultant to the Massachusetts Health Data Consortium on healthcare data security projects. He was co-founder, President, and CTO of Baranof Software, the leading vendor of service-level management software for messaging and Internet applications. Baranof was sold to Tally Systems in 1997. Ben has worked for Cisco Systems, Tumbleweed Communications, On Technology, Sun Microsystems, Symantec, Lotus, and BBN. In addition he has worked with a number of startup ventures including LocaModa.com, Zion.com, and CafeAbroad.com. He has spoken at the Open Group, The New England HIPAA Workgroup, ISSA, and numerous other conferences and was also an analyst with Ferris Research and Baroudi Bloor International.
Thank you to our hosts:
Join as a member Want unlimited access to everything The Capital Network has to offer?
Join as a member for access to events and more.
Join as a member
Want unlimited access to everything The Capital Network has to offer?